Covered recipient · General Payments record
RASHMI SANJAY
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$8,299.00
- Reported across 374 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $1,200.00 | 2 |
| Food and Beverage | $936.12 | 40 |
| Education | $25.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $675.00 | 1 |
| Acerta Pharma LLC | $661.20 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $121.34 | 5 |
| Daiichi Sankyo Inc. | $69.92 | 3 |
| ABBVIE INC. | $60.45 | 3 |
| Janssen Biotech, Inc. | $52.93 | 2 |
| EISAI INC. | $45.72 | 2 |
| PFIZER INC. | $41.09 | 2 |
| E.R. Squibb & Sons, L.L.C. | $32.69 | 1 |
| Immunocore Limited | $32.04 | 1 |
| Blueprint Medicines Corporation | $30.00 | 1 |
| Incyte Corporation | $27.06 | 1 |
| Genmab U.S., Inc. | $26.74 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.52 | 1 |
| Rigel Pharmaceuticals, Inc. | $26.44 | 1 |
| Tempus AI, Inc | $24.95 | 1 |
| Astellas Pharma US Inc | $24.80 | 1 |
| Merck Sharp & Dohme Corporation | $23.36 | 1 |
| Adaptive Biotechnologies Corporation | $23.12 | 1 |
| Gilead Sciences, Inc. | $22.45 | 1 |
| Alexion Pharmaceuticals, Inc. | $21.45 | 1 |
| SpringWorks Therapeutics, Inc. | $21.36 | 1 |
| Stryker Corporation | $21.23 | 1 |
| SOBI, INC | $18.78 | 1 |
| Deciphera Pharmaceuticals Inc. | $16.43 | 1 |
| Lilly USA, LLC | $15.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (43)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.